Preview

Patient-Oriented Medicine and Pharmacy

Advanced search

The significance of the PPARG gene in the recurrence of purulent complications after lower limb bone injury treatment

https://doi.org/10.37489/2949-1924-0088

EDN: VQBURC

Abstract

   Objective. To study the effect of the PPARG gene on the course of purulent complications after lower limb bone injury treatment.

   Materials and methods. A prospective genetic study was conducted involving 114 patients who were treated at the N.V. Solovyov Hospital (Yaroslavl) in the period from 2018 to 2024 for purulent-inflammatory complications after lower limb injuries from 2018 to 2024.

   The polymorphism of the PPARG C1431T gene (rs3856806), which plays a key role in the regulation of the inflammatory response and reparative processes, was used as the object of research.

   Genotyping was performed using real-time PCR followed by restriction analysis. Statistical data processing was performed using the χ2 criterion to assess the correspondence between genotype distribution and the Hardy–Weinberg equilibrium.

   Results. Analysis of the allelic distribution of the PPARG gene revealed the prevalence of the C allele in the total sample (82% in the main group and 89% in the control group). The most common genotype was C/C (70% and 80%, respectively), which indicates its association with a lower predisposition to infectious complications. The distribution of genotypes was in accordance with the Hardy-Weinberg equilibrium (p > 0.05), confirming the representativeness of the sample.

   Conclusion. The PPARG C1431T polymorphism is a significant predictor of the risk of developing and relapsing purulent complications in patients with lower limb injuries. Carriers of the T allele exhibit an increased likelihood of a prolonged inflammatory response, which requires a personalized approach to antibiotic therapy and early immunocorrection. To improve the accuracy of the forecast, it is necessary to take into account covariates, namely: metabolic disorders (BMI ≥ 30 kg/m2, type 2 diabetes mellitus), cardiovascular pathologies (hypertension, coronary heart disease).

About the Author

V. V. Savgachev
Yaroslavl State Medical University
Russian Federation

Vitaly V. Savgachev, Cand. Sci. (Med), associate professor

Department of Traumatology and Orthopedics

Yaroslavl


Competing Interests:

The author declares no conflict of interest



References

1. Savgachev V.V., Yurij A.V., Shubin L.B., et al. Database of algorithms for predictive efficiency of diagnosis, treatment, and prevention based on genetic polymorphism of high-risk pathologies in open fractures of leg bones. Certificate of database registration RU 2022621249, May 30, 2022. Application No. 2022621132 dated May 20, 2022. (In Russ.).

2. Visscher PM, Brown MA, McCarthy MI, Yang J. Five years of GWAS discovery. Am J Hum Genet. 2012 Jan 13;90(1):7-24. doi: 10.1016/j.ajhg.2011.11.029.

3. Zhou JQ, Liu ZX, Zhong HF, et al. Single nucleotide polymorphisms in the development of osteomyelitis and prosthetic joint infection : a narrative review. Front Immunol. 2024;5(15):1444469. Doi: 10.3389/fimmu.2024.1444469.

4. Loos RJF, Yeo GSH. The genetics of obesity: from discovery to biology. Nat Rev Genet. 2022 Feb; 23(2):120-133. doi: 10.1038/s41576-021-00414-z.

5. Song Y, Raheel TM, Jia A, et al. rs10865710 polymorphism in PPARG promoter is associated with the severity of type 2 diabetes mellitus and coronary artery disease in a Chinese population. Postgrad Med J. 2022 Oct 1;98(1164):778-787. doi: 10.1136/postgradmedj-2021-140354.

6. Hashemian L, Sarhangi N, Afshari M, et al. The role of the PPARG (Pro12Ala) common genetic variant on type 2 diabetes mellitus risk. J Diabetes Metab Disord. 2021 Aug 20;20(2):1385-1390. doi: 10.1007/s40200-021-00872-6.

7. Aisyah R, Sadewa AH, Patria SY, Wahab A. The PPARGC1A Is the Gene Responsible for Thrifty Metabolism Related Metabolic Diseases : A Scoping Review. Genes (Basel). 2022 Oct 18;13(10):1894. doi: 10.3390/genes13101894.

8. Lamagni T, Elgohari S, Harrington P. Trends in surgical site infections following orthopaedic surgery. Curr Opin Infect Dis. 2015 Apr;28(2):125-32. doi: 10.1097/QCO.0000000000000143.

9. Novakova ON, Novakov VB, Churnosov MI. Relationship between LYPLAL1 and TGFA gene polymorphisms and progression of knee osteoarthritis in residents of Central Chernozem Region of Russia. Traumatologiya i Ortopediya Rossii. 2022;28(4):42-53. (In Russ.). Doi: 10.17816/2311-2905-1979.

10. Kamensky AD, Donkina AI, Parakhin YV, et al. Role of gene polymorphisms in the development of aseptic instability of knee and hip endoprostheses : a literature review. Travmatologiya i Ortopediya Rossii. 2025;31(1):144-156. (In Russ.). doi: 10.17816/2311-2905-17487.

11. Paradowska-Gorycka A, Wojtecka-Lukasik E, Trefler J, et al. Association between IL-17F gene polymorphisms and susceptibility to and severity of rheumatoid arthritis (RA). Scand J Immunol. 2010;72(2):134-41. doi: 10.1111/j.1365-3083.2010.02411.x.


Review

For citations:


Savgachev V.V. The significance of the PPARG gene in the recurrence of purulent complications after lower limb bone injury treatment. Patient-Oriented Medicine and Pharmacy. 2025;3(2):36-41. (In Russ.) https://doi.org/10.37489/2949-1924-0088. EDN: VQBURC

Views: 43


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2949-1924 (Online)

Адрес редакции и издательства:

ООО «Издательство ОКИ»
115522, Москва, Москворечье ул., 4-5-129

Генеральный директор Афанасьева Елена Владимировна

Тел. + 7 (916) 986-04-65; Email: eva88@list.ru